[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@ThePharmaLetter Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::71542880.png) @ThePharmaLetter The Pharma Letter

The Pharma Letter posts on X about gilead sciences, combo, novartis, approved the most. They currently have XXXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::71542880/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::71542880/c:line/m:interactions.svg)

- X Week XXXXX +23%
- X Month XXXXX +175%
- X Months XXXXXX +92%
- X Year XXXXXX +8.20%

### Mentions: XX [#](/creator/twitter::71542880/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::71542880/c:line/m:posts_active.svg)

- X Week XX +11%
- X Month XX +95%
- X Months XXX +40%
- X Year XXX +98%

### Followers: XXXXXX [#](/creator/twitter::71542880/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::71542880/c:line/m:followers.svg)

- X Week XXXXXX +0.06%
- X Month XXXXXX +0.25%
- X Months XXXXXX +1.50%
- X Year XXXXXX +2.30%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::71542880/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::71542880/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::71542880/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXX% [countries](/list/countries)  XXXX% [finance](/list/finance)  XXXX%

**Social topic influence**
[gilead sciences](/topic/gilead-sciences) #81, [combo](/topic/combo) 1.11%, [novartis](/topic/novartis) 1.11%, [approved](/topic/approved) XXXX%

**Top accounts mentioned or mentioned by**
[@novonordisk](/creator/undefined) [@regeneron](/creator/undefined) [@novartis](/creator/undefined) [@novonordisks](/creator/undefined) [@atailife](/creator/undefined) [@abbvies](/creator/undefined) [@mercks](/creator/undefined) [@genmab](/creator/undefined) [@merusnv](/creator/undefined) [@celltrioninc](/creator/undefined) [@gileadsciences](/creator/undefined) [@pharmaessentia](/creator/undefined) [@beigeneglobal](/creator/undefined) [@beckleypsytech](/creator/undefined) [@actiobiosci](/creator/undefined) [@almirallus](/creator/undefined) [@sanofi](/creator/undefined) [@mhragovuk](/creator/undefined) [@bioversys](/creator/undefined) [@shionogijp](/creator/undefined)

**Top assets mentioned**
[Gilead Sciences, Inc. (GILD)](/topic/gilead-sciences) [Novartis AG (NVS)](/topic/novartis)
### Top Social Posts [#](/creator/twitter::71542880/posts)
---
Top posts by engagements in the last XX hours

"Breakthrough designation for @Genmabs Rina-S in USA"  
[X Link](https://x.com/ThePharmaLetter/status/1960974454424519164) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-08-28T07:55Z 25.3K followers, XXX engagements


"@novonordisk to boost MASH efforts with buy of @akerotx"  
[X Link](https://x.com/ThePharmaLetter/status/1976378743242490341) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-09T20:06Z 25.3K followers, XX engagements


"Grifols Biotest to launch Yimmugo in USA"  
[X Link](https://x.com/ThePharmaLetter/status/1976666619180122204) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-10T15:10Z 25.3K followers, XXX engagements


"NextPharma to sell logistics arm to @CencoraGlobal"  
[X Link](https://x.com/ThePharmaLetter/status/1978017636676981069) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-14T08:38Z 25.3K followers, XXX engagements


"@GileadSciences and @arcusbio see survival boost with gastric cancer combo"  
[X Link](https://x.com/ThePharmaLetter/status/1978384946772263123) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-15T08:58Z 25.3K followers, XX engagements


"Omnix Medical secures $XX million in Series C funding"  
[X Link](https://x.com/ThePharmaLetter/status/1978780428031922589) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-16T11:09Z 25.3K followers, XXX engagements


"@AstellasUS' zolbetuximab misses Phase II goal"  
[X Link](https://x.com/ThePharmaLetter/status/1978780568155234502) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-16T11:10Z 25.3K followers, XX engagements


"@OmerosCorp rockets on news of deal with @novonordisk"  
[X Link](https://x.com/ThePharmaLetter/status/1978780782081519832) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-16T11:11Z 25.3K followers, XX engagements


"@GileadSciences highlights HIV pipeline at European AIDS Conference"  
[X Link](https://x.com/ThePharmaLetter/status/1978781627397419414) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-16T11:14Z 25.3K followers, XX engagements


"@Regeneron plans FDA filing based on latest DB-OTO data"  
[X Link](https://x.com/ThePharmaLetter/status/1978019625435631889) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-14T08:46Z 25.3K followers, XX engagements


"ESMO 2025: PSMAddition data show @Novartis Pluvicto delays prostate cancer progression"  
[X Link](https://x.com/ThePharmaLetter/status/1980302261025927676) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-20T15:57Z 25.3K followers, XXX engagements


"@novonordisk's oral GLP-1 approved to cut MACE risk in type X diabetes patients"  
[X Link](https://x.com/ThePharmaLetter/status/1980307665709658460) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-20T16:18Z 25.3K followers, XX engagements


"FDA accepts @sanofi's Tzield for expedited review"  
[X Link](https://x.com/ThePharmaLetter/status/1980308285191499865) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-20T16:21Z 25.3K followers, XXX engagements